Free cookie consent management tool by TermsFeed GPCRmd
× Due to a recent server update, this page will be slow for the next 1-2 hours. We apologize for any inconvenience this may cause.


8th and Final ERNEST Meeting to Take Place in Crete with Participation from GPCR Drug Discovery Group

The 8th and final meeting of the European Research Network on Signal Transduction (ERNEST) is set to take place from May 3-7, 2023 in Crete. This event promises to be an exciting gathering of scientists from around the world who are interested in the latest developments in signal transduction research. Among the attendees will be several members of the G protein-coupled receptor (GPCR) Drug Discovery Group from the GRIB in Barcelona...Show all

Revolutionary Alpha Fold Algorithm Unveiled: A Game-Changer for Protein Folding and Drug Discovery

In a groundbreaking new publication, researchers have unveiled the latest advancements in the field of protein folding. The publication, titled "Alpha Fold: a solution to a 50-year-old grand challenge in biology," details the creation of a powerful algorithm that can predict the three-dimensional structures of proteins with unprecedented accuracy. This breakthrough has the potential to revolutionize drug discovery, as it provides a more efficient way to design and develop new drugs that can target specific proteins...Show all

Second simulation round

After our first successful publication in Nature Methods, we are back to increase the data coverage of GPCRmd in a 2nd simulation round...Show all

Nature publication: GPCRmd uncovers the dynamics of the 3D-GPCRom

A groundbreaking paper titled "GPCRmd uncovers the dynamics of the 3D-GPCRome" has just been published, offering new insights into the dynamics of G protein-coupled receptors (GPCRs), a class of proteins that play a crucial role in signaling pathways. The paper details the findings of the GPCRmd project, a collaborative effort between several research institutions to create a comprehensive database of GPCR molecular dynamics simulations...Show all


ERNEST (COST Action CA18133)

GLISTEN (COST Action CM1207)